DB-160

N/A

Report date: 2026/05/12 20:00:17
NME

Base Information

Drug NameDB-160
Drug Alias Namedipeptidyl peptidase IV inhibitor (DARA BioSciences)DB-160
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDipeptidyl peptidase IV inhibitorsGlucagon-like peptide 1 receptor agonists
TargetsDipeptidyl peptidase IVGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2 +[2] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFortovia Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFortovia Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2 +[2] 

Other Information

ATC CodeN/A
Related LinksN/A